• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

透明质酸/透明质酸酶作为膀胱癌的生物标志物:一项诊断性荟萃分析。

Hyaluronic acid/ Hyaluronidase as biomarkers for bladder cancer: a diagnostic meta-analysis.

出版信息

Neoplasma. 2017;64(6):901-908. doi: 10.4149/neo_2017_612.

DOI:10.4149/neo_2017_612
PMID:28895415
Abstract

This study aimed to determine the value of HA/HAase for detecting bladder cancer on the basis of preceding statistical performance. PubMed, Springer Link, Web of Science and Cochrane Library were systematically searched to identify potentially relevant published articles by using the key words: "bladder cancer or bladder tumor or bladder carcinoma", "hyaluronic acid or hyaluronan", "hyaluronidase or HAase". The methodological quality of each study was assessed by QUADAS-2. According to the inclusive and exclusive criteria, 8 articles were identified and methodologically analyzed by STATA 12.0 software package.The results showed that the pooled sensitivity of HA and HAase was 0.832 (95% confidence interval [CI]: 0.798, 0.861) and 0.834 (95% CI: 0.756, 0.891) respectively, the pooled specificity was 0.886 (95% CI: 0.852, 0.913) and 0.860 (95% CI: 0.801, 0.904), and the area under the summary ROC cure (AUC) was 0.90 (95% CI: 0.87, 0.92) and 0.91 (95% CI: 0.88, 0.93), respectively. Simultaneously the diagnostic accuracy of the combination of HA and HAase showed that the pooled sensitivity was 0.908 (95% CI: 0.879, 0.931), the pooled specificity was 0.825 (95% CI: 0.789, 0.856) and AUC was 0.94 (95% CI: 0.91, 0.95), indicating a relatively higher accuracy than HA and HAase alone. This meta-analysis strongly suggests that HA/HAase could be used as biomarkers for the diagnosis of bladder cancer.

摘要

本研究旨在根据先前的统计性能,确定 HA/HAase 在膀胱癌检测中的价值。通过使用关键词“膀胱癌或膀胱肿瘤或膀胱癌”、“透明质酸或透明质酸盐”、“透明质酸酶或 HAase”,系统地在 PubMed、Springer Link、Web of Science 和 Cochrane Library 中搜索潜在相关的已发表文章,以识别潜在相关的已发表文章。使用 QUADAS-2 评估每项研究的方法学质量。根据纳入和排除标准,确定 8 篇文章,并使用 STATA 12.0 软件包进行方法学分析。结果表明,HA 和 HAase 的合并敏感性分别为 0.832(95%置信区间[CI]:0.798,0.861)和 0.834(95%CI:0.756,0.891),合并特异性分别为 0.886(95%CI:0.852,0.913)和 0.860(95%CI:0.801,0.904),汇总 ROC 曲线下面积(AUC)分别为 0.90(95%CI:0.87,0.92)和 0.91(95%CI:0.88,0.93)。同时,HA 和 HAase 联合检测的诊断准确性表明,合并敏感性为 0.908(95%CI:0.879,0.931),合并特异性为 0.825(95%CI:0.789,0.856),AUC 为 0.94(95%CI:0.91,0.95),表明准确性相对高于单独使用 HA 和 HAase。这项荟萃分析强烈表明,HA/HAase 可以用作膀胱癌诊断的生物标志物。

相似文献

1
Hyaluronic acid/ Hyaluronidase as biomarkers for bladder cancer: a diagnostic meta-analysis.透明质酸/透明质酸酶作为膀胱癌的生物标志物:一项诊断性荟萃分析。
Neoplasma. 2017;64(6):901-908. doi: 10.4149/neo_2017_612.
2
Urinary hyaluronic acid and hyaluronidase: markers for bladder cancer detection and evaluation of grade.尿透明质酸和透明质酸酶:膀胱癌检测及分级评估的标志物。
J Urol. 2000 Jan;163(1):348-56. doi: 10.1016/s0022-5347(05)68050-0.
3
Elevated tissue expression of hyaluronic acid and hyaluronidase validates the HA-HAase urine test for bladder cancer.透明质酸和透明质酸酶的组织表达升高验证了用于膀胱癌的HA-HAase尿液检测。
J Urol. 2001 Jun;165(6 Pt 1):2068-74. doi: 10.1097/00005392-200106000-00072.
4
[Hyaluronic acid and hyaluronidase. 2 new bladder carcinoma markers].[透明质酸与透明质酸酶。两种新型膀胱癌标志物]
Urologe A. 2001 Mar;40(2):121-6. doi: 10.1007/s001200050449.
5
Bladder tumor markers for monitoring recurrence and screening comparison of hyaluronic acid-hyaluronidase and BTA-Stat tests.用于监测复发的膀胱肿瘤标志物以及透明质酸-透明质酸酶与BTA-Stat检测的筛查比较
Cancer. 2002 Jul 1;95(1):61-72. doi: 10.1002/cncr.10652.
6
Diagnostic value of urinary survivin as a biomarker for bladder cancer: a systematic review and meta-analysis of published studies.尿生存素作为膀胱癌生物标志物的诊断价值:系统评价和荟萃分析。
World J Urol. 2018 Sep;36(9):1373-1381. doi: 10.1007/s00345-018-2285-8. Epub 2018 Apr 2.
7
Sensitivity and specificity of urinary hyaluronic acid and hyaluronidase in detection of bladder transitional cell carcinoma.尿透明质酸和透明质酸酶检测膀胱移行细胞癌的敏感性和特异性
Urol J. 2014 Mar 3;11(1):1232-7.
8
Immunocyt and the HA-HAase urine tests for the detection of bladder cancer: a side-by-side comparison.免疫细胞检测和HA-HAase尿液检测用于膀胱癌检测:并列比较
Eur Urol. 2004 Oct;46(4):466-71. doi: 10.1016/j.eururo.2004.06.006.
9
One-step facile synthesis of hyaluronic acid functionalized fluorescent gold nanoprobes sensitive to hyaluronidase in urine specimen from bladder cancer patients.一步简便合成对膀胱癌患者尿液样本中的透明质酸酶敏感的透明质酸功能化荧光金纳米探针。
Talanta. 2014 Dec;130:408-14. doi: 10.1016/j.talanta.2014.07.005. Epub 2014 Jul 10.
10
HA-HAase urine test. A sensitive and specific method for detecting bladder cancer and evaluating its grade.HA-透明质酸酶尿液检测。一种用于检测膀胱癌并评估其分级的灵敏且特异的方法。
Urol Clin North Am. 2000 Feb;27(1):53-61. doi: 10.1016/s0094-0143(05)70234-2.

引用本文的文献

1
Hyaluronidase: structure, mechanism of action, diseases and therapeutic targets.透明质酸酶:结构、作用机制、疾病及治疗靶点
Mol Biomed. 2025 Jul 12;6(1):50. doi: 10.1186/s43556-025-00299-y.
2
Antibody-drug conjugate monotherapy refines the oncological efficacy as compared to therapy of physicians' choices in advanced breast cancers: a systematic review and meta-analysis.与晚期乳腺癌医生选择的治疗方法相比,抗体药物偶联物单一疗法可提高肿瘤学疗效:一项系统评价和荟萃分析。
Transl Breast Cancer Res. 2023 Apr 30;4:11. doi: 10.21037/tbcr-23-14. eCollection 2023.
3
The predictive value of [TIMP-2]*[IGFBP7] in adverse outcomes for acute kidney injury: a systematic review and meta-analysis.
[TIMP-2]*[IGFBP7] 对急性肾损伤不良结局的预测价值:系统评价和荟萃分析。
Ren Fail. 2023;45(2):2253933. doi: 10.1080/0886022X.2023.2253933. Epub 2023 Sep 19.
4
Urine biomarkers in bladder cancer - current status and future perspectives.膀胱癌中的尿液生物标志物——现状与未来展望
Nat Rev Urol. 2023 Oct;20(10):597-614. doi: 10.1038/s41585-023-00773-8. Epub 2023 May 24.
5
Altered Glycosylation in Progression and Management of Bladder Cancer.膀胱癌进展和管理中的糖基化改变。
Molecules. 2023 Apr 13;28(8):3436. doi: 10.3390/molecules28083436.
6
Hyaluronidase-trigger nanocarriers for targeted delivery of anti-liver cancer compound.用于靶向递送抗肝癌化合物的透明质酸酶触发纳米载体。
RSC Adv. 2023 Apr 11;13(16):11160-11170. doi: 10.1039/d3ra00693j. eCollection 2023 Apr 3.
7
Predictive value of urinary cell cycle arrest biomarkers for all cause-acute kidney injury: a meta-analysis.尿细胞周期停滞生物标志物对全因急性肾损伤的预测价值:一项荟萃分析。
Sci Rep. 2023 Apr 13;13(1):6037. doi: 10.1038/s41598-023-33233-9.
8
Proteomics for Early Detection of Non-Muscle-Invasive Bladder Cancer: Clinically Useful Urine Protein Biomarkers.蛋白质组学用于非肌层浸润性膀胱癌的早期检测:具有临床应用价值的尿液蛋白质生物标志物
Life (Basel). 2022 Mar 9;12(3):395. doi: 10.3390/life12030395.
9
Comparison of the Oncological Efficacy Between Intraoperative Radiotherapy With Whole-Breast Irradiation for Early Breast Cancer: A Meta-Analysis.早期乳腺癌术中放疗与全乳照射的肿瘤学疗效比较:一项Meta分析
Front Oncol. 2021 Dec 17;11:759903. doi: 10.3389/fonc.2021.759903. eCollection 2021.
10
Stereotactic Biopsy for Brainstem Lesions: A Meta-analysis with Noncomparative Binary Data.脑干病变立体定向活检:一项基于非比较二项数据的荟萃分析。
Cancer Control. 2021 Jan-Dec;28:10732748211059858. doi: 10.1177/10732748211059858.